A South Korean regulator said Wednesday Samsung Biologics Co. breached accounting rules in a preliminary finding that could deal a big blow to the company and other Samsung affiliates if finalized. Financial Supervisory Service wrapped up its one-year probe into Samsung Biologics and notified the company of the violation. It declined to confirm details of…